We compared the sensitivities of the prototype human T-cell lymphotropic virus type I (HTLV-I)-and HTLV-II-transformed cell lines, MT2 and Mo-T, with that of an HTLV-II-infected cell line, clone 19, established in our laboratory, in the immunofluorescence (IF) In the IF test, the specimens are screened on both HTLV-I-and HTLV-II-infected cells by using the prototype cell strains, MT2 and Mo-T. Sera with high antibody titers fluoresce brightly with both antigens, regardless of the infecting HTLV type. However, low-titered sera usually react more strongly with the homologous antigen, and very weakly reactive sera may fluoresce only with the homologous antigen (3). Although we have found the IF test to be more sensitive than the currently licensed EIA kits (2) HTLV-II serology without patient identifiers. The specimens were screened by EIA (Abbott Laboratories, North Chicago, Ill.) according to the directions of the manufacturer and by IF as previously described (4).
We compared the sensitivities of the prototype human T-cell lymphotropic virus type I (HTLV-I)-and HTLV-II-transformed cell lines, MT2 and Mo-T, with that of an HTLV-II-infected cell line, clone 19, established in our laboratory, in the immunofluorescence (IF) test for detection of antibody to HTLV-I and HTLV-II. In addition, IF antibody titers with the three antigens were determined, and the results were compared with HTLV-I and HTLV-II typing by polymerase chain reaction (PCR). The MT2 cell line was more sensitive than the two HTLV-II cell lines for detecting HTLV-I antibody by IF, and clone 19 was more sensitive than Mo-T or MT2 for measuring HTLV-II antibody. In the titration study, the antigen that gave the highest titer correlated completely with the HTLV type determined by PCR, indicating that the relatively simple IF titration method can be used for differentiating HTLV-I and HTLV-II antibody in sera and plasmas.
We use the enzyme immunoassay (EIA) and the indirect immunofluorescence (IF) test to screen sera for antibody to human T-cell lymphotropic virus type I and type II (HTLV-I and HTLV-II). The Western immunoblot (WB) and the radioimmunoprecipitation assay (RIPA) are employed when the results of the EIA and IF screening methods do not agree (4) . Because HTLV-I and HTLV-II have approximately 60% genetic homology, these serologic methods detect antibody to both types.
In the IF test, the specimens are screened on both HTLV-I-and HTLV-II-infected cells by using the prototype cell strains, MT2 and Mo-T. Sera with high antibody titers fluoresce brightly with both antigens, regardless of the infecting HTLV type. However, low-titered sera usually react more strongly with the homologous antigen, and very weakly reactive sera may fluoresce only with the homologous antigen (3 II  1+  1+  1+  8  8  16  -30  II  -1+  1+   <8  8  16  -31  II  --1+   <8  <8 16 -a As determined by PCR. b Degree of fluorescence (1+ to 4+) at 1:10 dilution. ' Reciprocal of highest dilution exhibiting 1 + fluorescence.
substrates. These specimens were submitted either as sera or clotted whole blood, so peripheral blood mononuclear cells were not available for PCR typing.
The plasmas from a separate group of heparinized whole blood specimens were screened for HTLV-I and HTLV-T1 antibody, and PCR was performed with the peripheral blood mononuclear cells of the reactive samples. Plasmas from 11 HTLV-I-and 20 HTLV-II-infected individuals, as determined by PCR typing, were titrated against the three antigens (Table 1 
